Cases & Deals

Share

Stentys completes €12.6 million rights issue

March 2016

Client(s) Stentys

Jones Day advised Stentys, a French medical device company developing and commercializing innovative solutions for the treatment of patients with complex coronary artery disease, and Société Générale & Investment Banking, as lead manager and bookrunner, in connection with the €12.6 million (US$13.8 million) rights issue in a public offering in France and related private placement.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.